DNMT3A is commonly mutated in myeloid diseases, with mutations found in over 20% of all acute myeloid leukemia (AML) patients [1], in 8% of myelodysplastic syndrome (MDS) patients [2], and in smaller frequencies in other leukemias. This evidence concerns the gene DNMT3A and myelodysplastic syndrome.